Exosome therapy uses cell-derived messengers, sometimes called extracellular vesicles, to support the body’s own signaling in a targeted area. At RegenHaus Medical in Alpharetta, exosome therapy in Atlanta is physician-supervised, carefully sourced, and explained honestly, including what the FDA does and does not approve.
Physician-led · Same-week appointments · No obligation
Healing depends on cells communicating with each other. Signaling molecules tell surrounding tissue when to repair and when to calm inflammation. That communication can slow with age or after an injury, leaving tissue waiting on instructions that arrive more slowly than they once did.
The instructions that tell tissue when to repair and when to calm inflammation.
Supplies cell-derived signaling material to a targeted area to support that communication.
A reasonable choice for many people. Exosome therapy is not the right answer for everyone.
It is not right for everyone, which is the first thing we establish at your consultation.
Exosomes are tiny particles released by cells, sometimes called extracellular vesicles. They carry signaling material such as growth factors from one cell to another. They are not cells themselves, and that distinction is where most marketing about them goes wrong.
Particles released by cells that carry signals to other cells. They are not stem cells, and they are not a drug.
Exosome therapy can be used on its own for targeted support, or alongside other regenerative care. What applies to you is decided in a consultation, not chosen from a menu.
A joint injection is targeted. The material is placed into one joint space rather than circulated through the body, which is what makes accurate placement matter. Your physician explains what applies to your case.
We review your history and goals, and confirm whether this is appropriate at all.
Your physician selects the approach and confirms product sourcing before anything is scheduled.
Performed in office, or at your home where clinically appropriate.
Aftercare instructions, then monitoring of your response over the following months.
There are no FDA-approved exosome products. The FDA regulates exosomes intended to treat disease as drugs or biologics, which means a product used that way would require an approval it does not have.
The FDA has publicly warned about unapproved exosome products following documented serious adverse events, and sourcing quality is the issue behind those warnings. That is precisely why physician oversight and verified sourcing matter here. We tell you the regulatory status and the sourcing of anything recommended to you before you decide, and we will tell you when the honest answer is that the evidence does not support what you are hoping for.
Joint discomfort and degeneration, alongside other regenerative care
Chronic tendinopathy and soft tissue irritation
Recovery support after injury or physical stress
Targeted support within an existing regenerative plan
Use alongside orthobiologics or joint injections
| Option | What It Does | Timeline | Trade-Off |
|---|---|---|---|
| Exosomes | Delivers cell-free signaling material | Weeks to a few months | No FDA-approved products exist. Evidence is early and varies by application. |
| Stem cells | Delivers cells that can develop into other types | Weeks to a few months | A different material with a different regulatory picture and a different evidence base. |
| PRP | Prepared from your own blood | Weeks | Listed here for comparison only. Different preparation and different evidence. |
Exosomes are not stem cells, and exosome therapy is not a stronger version of it. They are signals rather than cells, which is a different mechanism entirely.
A consultation is how you find out. We explain what the evidence supports, where our material is sourced, and whether this is a reasonable option for you.
The same physician evaluates you, supervises treatment, and manages follow-up.
Because sourcing quality is the safety issue the FDA has flagged.
We separate what research supports from what is preliminary, before you decide.
Where clinically appropriate, care can be delivered at your home or office.
Connected to our orthobiologics, joint injection, and longevity programs. Meet the physicians.
Research on exosomes is early, and stronger for some applications than others. We tell you what applies to your case. See our research.
Any change develops gradually over weeks to a few months. Some patients do not respond, and we track for that.
There are no FDA-approved exosome products, and the FDA has warned about unapproved ones. We state that plainly rather than talk around it.
Screening comes first. Your physician reviews your history, medications, and prior treatment before anything is scheduled, and confirms the sourcing of any product used. Reported risks include infection, injection site reaction, immune response, and temporary soreness. We will not tell you exosome therapy carries no immune risk, because that would not be true.
You are generally not a candidate if you have
Exosome therapy may not be covered by insurance, and coverage varies by plan, so contact us for individualized treatment and payment information.
RegenHaus Medical is on North Point Parkway in Alpharetta, just off GA 400. Patients travel to us from across North Fulton and Forsyth County, including Johns Creek, Milton, Roswell, Cumming, Suwanee, Sandy Springs, and Buckhead. See all areas we serve.
Exosomes are tiny particles released by cells, sometimes called extracellular vesicles, that carry signaling material such as growth factors between cells. In exosome therapy, that material is applied to a targeted area to support local cell communication.
No. Stem cells are cells that can develop into other cell types. Exosomes are signals released by cells, not cells themselves. Clinics that use the terms interchangeably are describing different things.
There are no FDA-approved exosome products. The FDA regulates exosomes intended to treat disease as drugs or biologics, and has warned about unapproved exosome products following documented serious adverse events. We tell every patient this before any discussion of treatment.
Reported risks include infection, injection site reaction, immune response, and temporary soreness. We will not claim exosome therapy carries no immune risk. Screening and verified sourcing are how risk is managed, not eliminated.
Sourcing is confirmed by your physician before anything is scheduled, and we will tell you the source of any product recommended to you. Sourcing quality is the specific issue behind the FDA’s warnings, so ask any provider this.
It may not be, and coverage varies by plan. Contact us for individualized treatment and payment information.
If you are trying to work out whether exosome therapy is legitimate, the next step is a conversation with a physician. We explain what exosomes are, what the FDA has and has not approved, where our material is sourced, and whether any of it applies to you.
I had been struggling with chronic knee pain for years, and nothing seemed to help—until I found RegenHaus Medical. Their non-invasive approach made a world of difference. I’m now walking pain-free and even back to enjoying my morning jogs. I can’t thank them enough!
Sarah T. Alpharetta, GA